Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alkuri Global Acquisition was a special purpose acquisition company (SPAC) formed to consummate a business combination and completed a reverse merger with Babylon Holdings/Babylon Healthcare Services in October 2021, after which Babylon began trading on the NYSE as BBLN and Alkuri ceased to exist as an independent operating entity.[1][5][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alkuri Global Acquisition.